Convelo:
News & Press Releases
March 6, 2024
Convelo Therapeutics is developing two experimental oral treatments to promote myelin repair in multiple sclerosis (MS) and both have shown promise in preclinical models. The company is in the final stages of …
November 7, 2023
Case Western Reserve University has established an institute devoted to a research subject that university experts see as the next crucial area of medical research…
April 6, 2020
Multiple sclerosis (MS) is a debilitating disease in which the body’s own immune system attacks itself and can, over time, permanently destroy the protective sheaths, or myelin, around nerve…
November 13, 2019
CLEVELAND, Ohio – We’re pleased to announce PhD Paul Tesar as winner of the cleveland.com HomeGrown Heroes award in the Academic Research category. Tesar, along with…
July 16, 2019
CLEVELAND, OHIO — Convelo Therapeutics, Inc., a biotechnology company with a mission to discover a new class of medicines that regenerate the protective myelin coating around nerve cells, has entered into an exclusive worldwide …
March 26, 2019
Dr. Tesar (Associate Professor and Director of the Pluripotent Stem Cell Facility at Case Western Reserve School of Medicine) was telling the story of Convelo, the company he created to develop treatments for diseases such as multiple sclerosis. He and fellow…
August 16, 2018
Enzymes downstream in cholesterol biosynthesis could provide new ways to stimulate remyelination that avoid the baggage of previously identified multiple sclerosis targets, according to a group at Case Western. The university is spinning out Convelo Therapeutics Inc. to translate the idea. …
July 25, 2018
CLEVELAND, OHIO — Convelo Therapeutics, Inc. announced today that it has launched from stealth mode with a mission to discover and develop a new class of medicines that regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases, including multiple sclerosis (MS). Seminal scientific discoveries…
July 25, 2018
Convelo Therapeutics launched publicly on Wednesday, July 25, after working in stealth mode with a mission to discover and develop a new class of medicines for neurological disease characterized by the loss of the protective Myelin coating around nerve cells, according to a news release. …
July 25, 2018
With research from Case Western Reserve University, a Cleveland-based startup aims to develop a new class of medicines that help regenerate the insulating myelin sheath around nerve cells, which is degraded in neurological disorders such as multiple sclerosis. Convelo Therapeutics—its name comes from…
